Targeting skeletal muscle lipid turnover and the balance between lipolysis, FA uptake, and mitochondrial function/fat oxidation may be an attractive strategy with which to improve insulin sensitivity in obesity and T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.